How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code NIG: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer. View classification details, related manufacturers, 510(k) clearances, and recall records.
An in vitro diagnostic test for the quantitative measurement of the CA 19-9 tumor associated antigen in human serum or plasma. The test is intended as an aid in the management of patients with confirmed pancreatic cancer and serial monitoring of their response to therapy and disease progression. The test should only be used in patients with serum and plasma CA 19-9 values above the cut-off at the time of diagnosis and in conjunction with other clinical methods.Explore immunology records →
12 clearance records and 19 recall records in the covered releases, across 12 source company names and 1 product codes. Dated history runs from May 9, 2002 to Aug 10, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 1 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| NIG · System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer | 12 | 19 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ARCHITECT CA 19-9 Reagent Kit, list 6C04-20 (1 x 100 tests) and 6C04-25 (4 x 100 tests), Abbott laboratories, Abbott Park, IL 60064 U.S.A.Z-0781-04 · NIG | Abbott Laboratories HPD/ADD/GPRD | Recall | Jul 20, 2004FDA classification date |
| GI MONITOR AND GI MONITOR CALIBRATORS ON THE ACCESS IMMUNOASSAY SYSTEMS, MODEL 387687, 387688K033038 · NIG | Beckman Coulter, Inc. | 510(k) | Dec 29, 2003FDA decision date |
| BAYER ADVIA CENTAUR CA 19-9 ASSAYK031393 · NIG | Bayer Healthcare, LLC | 510(k) | Jun 24, 2003FDA decision date |
| AIA-PACK CA 19-9K023239 · NIG | Tosoh Corp. | 510(k) | Dec 23, 2002FDA decision date |
| ST AIA-PACK CA 19-9K023240 · NIG | Tosoh Corp. | 510(k) | Dec 23, 2002FDA decision date |
| FUJIREBIO DIAGNOSTICS CA 19-9 RIAK020566 · NIG | Fujirebio Diagnostics,Inc. | 510(k) | May 9, 2002FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.